Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
BMS, AstraZeneca, Novartis Add to 2024 M&A Upswing
BioSpace
Mon, 03/18/24 - 11:10 am
M&A
Bristol Myers Squibb
Novartis
AstraZeneca
Novo Nordisk
Pfizer
Eli Lilly strikes deal with Amazon: Will the ecommerce giant become go-to destination for GLP-1s?
Biopharma Reporter
Mon, 03/18/24 - 11:02 am
Eli Lilly
Novo Nordisk
GLP-1 agonist
Zepbound
Wegovy
Amazon
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Asgard Therapeutics
JNJ
Novo Nordisk
Boehringer Ingelheim
funding
immuno-oncology
Lilly weight-loss drug Zepbound new US prescriptions surpass Wegovy for first time
Reuters
Sun, 03/17/24 - 09:17 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weight loss
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Asgard Therapeutics
in vivo cell therapy
cell therapy
JNJ
Novo Nordisk
How the Ozempic gold rush is causing ‘deeply concerning’ shortage for diabetes patients
Biopharma Reporter
Wed, 03/13/24 - 11:16 am
Ozempic
Novo Nordisk
GLP-1
diabetes
drug shortages
Novo Nordisk-owner to expand in India this year
Reuters
Tue, 03/12/24 - 06:50 pm
Novo Nordisk
Novo Holdings
India
Novo Nordisk working with global authorities to take down fake Ozempic
Beckers Hospital Review
Mon, 03/11/24 - 05:03 pm
Novo Nordisk
drug counterfeiting
Ozempic
FDA clears use of Novo’s obesity drug to protect heart health
BioPharma Dive
Sun, 03/10/24 - 08:43 pm
Novo Nordisk
FDA
Wegovy
Novo Nordisk confident of amycretin obesity drug launch this decade
Reuters
Fri, 03/8/24 - 11:09 am
Novo Nordisk
amycretin
weight loss
obesity
Launches and prices of Novo Nordisk's weight-loss drug Wegovy
Reuters
Fri, 03/8/24 - 10:59 am
Novo Nordisk
drug launches
Wegovy
drug pricing
weight loss
Novo valuation surpasses Tesla on experimental obesity drug data
Reuters
Thu, 03/7/24 - 11:40 am
Novo Nordisk
obesity
weight loss
clinical trials
amycretin
Novo kidney trial finds Ozempic cuts cardiac risks in diabetics
Reuters
Tue, 03/5/24 - 11:52 am
Novo Nordisk
Ozempic
clinical trials
diabetes
chronic kidney disease
Novo Nordisk's new Boston-area campus reflects 'competitive' R&D growth, and not just for GLP-1s
Fierce Biotech
Thu, 02/29/24 - 11:16 am
Novo Nordisk
Boston
R&D
Massachusetts
Novo Nordisk doles out $1.4B for molecular glue degraders licensing pact
Medical Marketing and Media
Mon, 02/26/24 - 05:18 pm
Novo Nordisk
molecular glue degraders
Neomorph
R&D
Weight-loss drugs could boost US GDP by 1% in coming years, Goldman says
Reuters
Thu, 02/22/24 - 11:14 pm
obesity
weight loss
GLP-1 agonist
Novo Nordisk
Eli Lilly
Novo Nordisk, Eli Lilly lead industrywide sales surge in Q4
Fierce Pharma
Thu, 02/22/24 - 11:12 pm
earnings
Novo Nordisk
Eli Lilly
obesity
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Novo Nordisk
Novartis
JNJ
Bristol Myers Squibb
legal
Inflation Reduction Act
drug pricing
Actually Wegovy is good for dialysis companies, dialysis provider says
Stat
Wed, 02/21/24 - 11:12 am
Wegovy
Novo Nordisk
dialysis
Fresenius Medical Care
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
BioSpace
Tue, 02/20/24 - 05:55 pm
market cap
Eli Lilly
JNJ
Novo Nordisk
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »